000 01377 a2200373 4500
005 20250513043501.0
264 0 _c19950714
008 199507s 0 0 eng d
022 _a0105-4538
024 7 _a10.1111/j.1398-9995.1995.tb04253.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAlexander, M
245 0 0 _aComparative therapeutic studies with Tilavist.
_h[electronic resource]
260 _bAllergy
_c1995
300 _a23-9; discussion 34-8 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Review
650 0 4 _aAdministration, Oral
650 0 4 _aAdministration, Topical
650 0 4 _aAllergens
_xadverse effects
650 0 4 _aClinical Trials as Topic
650 0 4 _aConjunctiva
_xdrug effects
650 0 4 _aConjunctivitis, Allergic
_xdrug therapy
650 0 4 _aCromolyn Sodium
_xadministration & dosage
650 0 4 _aDouble-Blind Method
650 0 4 _aHistamine H1 Antagonists
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aMulticenter Studies as Topic
650 0 4 _aNedocromil
_xadministration & dosage
650 0 4 _aOphthalmic Solutions
650 0 4 _aPollen
650 0 4 _aRandomized Controlled Trials as Topic
773 0 _tAllergy
_gvol. 50
_gno. 21 Suppl
_gp. 23-9; discussion 34-8
856 4 0 _uhttps://doi.org/10.1111/j.1398-9995.1995.tb04253.x
_zAvailable from publisher's website
999 _c7785113
_d7785113